Annual CFI
-$1.63 M
-$593.00 K-56.96%
December 31, 2023
Summary
- As of February 7, 2025, PHAT annual cash flow from investing activities is -$1.63 million, with the most recent change of -$593.00 thousand (-56.96%) on December 31, 2023.
- During the last 3 years, PHAT annual CFI has fallen by -$594.00 thousand (-57.12%).
Performance
PHAT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$44.00 K
+$2000.00+4.35%
September 30, 2024
Summary
- As of February 7, 2025, PHAT quarterly cash flow from investing activities is -$44.00 thousand, with the most recent change of +$2000.00 (+4.35%) on September 30, 2024.
- Over the past year, PHAT quarterly CFI has increased by +$2000.00 (+4.35%).
Performance
PHAT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$605.00 K
+$895.00 K+59.67%
September 30, 2024
Summary
- As of February 7, 2025, PHAT TTM cash flow from investing activities is -$605.00 thousand, with the most recent change of +$895.00 thousand (+59.67%) on September 30, 2024.
- Over the past year, PHAT TTM CFI has increased by +$895.00 thousand (+59.67%).
Performance
PHAT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PHAT Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -57.0% | +4.3% | +59.7% |
3 y3 years | -57.1% | +89.3% | +41.9% |
5 y5 years | -100.0% | +89.3% | +41.9% |
PHAT Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -398.2% | at low | -633.3% | +95.3% | -167.7% | +63.0% |
5 y | 5-year | -398.2% | +93.5% | -633.3% | +95.3% | -167.7% | +97.7% |
alltime | all time | <-9999.0% | +93.5% | <-9999.0% | +99.8% | <-9999.0% | +97.7% |
Phathom Pharmaceuticals Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$44.00 K(-4.3%) | -$605.00 K(-59.7%) |
Jun 2024 | - | -$46.00 K(+15.0%) | -$1.50 M(+2.7%) |
Mar 2024 | - | -$40.00 K(-91.6%) | -$1.46 M(-10.6%) |
Dec 2023 | -$1.63 M(+57.0%) | -$475.00 K(-49.4%) | -$1.63 M(+4.0%) |
Sep 2023 | - | -$939.00 K(>+9900.0%) | -$1.57 M(+105.1%) |
Jun 2023 | - | -$6000.00(-97.2%) | -$766.00 K(-35.5%) |
Mar 2023 | - | -$214.00 K(-48.1%) | -$1.19 M(+14.1%) |
Dec 2022 | -$1.04 M(+217.4%) | -$412.00 K(+207.5%) | -$1.04 M(+42.8%) |
Sep 2022 | - | -$134.00 K(-68.7%) | -$729.00 K(+19.7%) |
Jun 2022 | - | -$428.00 K(+538.8%) | -$609.00 K(+169.5%) |
Mar 2022 | - | -$67.00 K(-33.0%) | -$226.00 K(-31.1%) |
Dec 2021 | -$328.00 K | -$100.00 K(+614.3%) | -$328.00 K(-6.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$14.00 K(-68.9%) | -$352.00 K(-32.4%) |
Jun 2021 | - | -$45.00 K(-73.4%) | -$521.00 K(-2.3%) |
Mar 2021 | - | -$169.00 K(+36.3%) | -$533.00 K(-48.8%) |
Dec 2020 | -$1.04 M(-95.9%) | -$124.00 K(-32.2%) | -$1.04 M(+1.8%) |
Sep 2020 | - | -$183.00 K(+221.1%) | -$1.02 M(+18.2%) |
Jun 2020 | - | -$57.00 K(-91.6%) | -$865.00 K(-96.7%) |
Mar 2020 | - | -$676.00 K(+537.7%) | -$25.93 M(+2.7%) |
Dec 2019 | -$25.25 M(<-9900.0%) | -$106.00 K(+307.7%) | -$25.25 M(+0.4%) |
Sep 2019 | - | -$26.00 K(-99.9%) | -$25.14 M(+0.1%) |
Jun 2019 | - | -$25.12 M(<-9900.0%) | -$25.12 M(<-9900.0%) |
Mar 2019 | - | $0.00 | $0.00 |
Dec 2018 | $0.00 | - | - |
FAQ
- What is Phathom Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals annual CFI year-on-year change?
- What is Phathom Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly CFI year-on-year change?
- What is Phathom Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals TTM CFI year-on-year change?
What is Phathom Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of PHAT is -$1.63 M
What is the all time high annual CFI for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual cash flow from investing activities is $0.00
What is Phathom Pharmaceuticals annual CFI year-on-year change?
Over the past year, PHAT annual cash flow from investing activities has changed by -$593.00 K (-56.96%)
What is Phathom Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of PHAT is -$44.00 K
What is the all time high quarterly CFI for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly cash flow from investing activities is $0.00
What is Phathom Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, PHAT quarterly cash flow from investing activities has changed by +$2000.00 (+4.35%)
What is Phathom Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of PHAT is -$605.00 K
What is the all time high TTM CFI for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high TTM cash flow from investing activities is $0.00
What is Phathom Pharmaceuticals TTM CFI year-on-year change?
Over the past year, PHAT TTM cash flow from investing activities has changed by +$895.00 K (+59.67%)